Verastem reported $144M in Market Capitalization this January of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US USD 237.3B 33.36B
AstraZeneca AZN:LN USD 154.08B 13.26B
Curis CRIS:US USD 64M 26M
Cytokinetics CYTK:US USD 4.56B 1.2B
Gilead Sciences GILD:US USD 77.36B 170M
Immunogen IMGN:US USD 1.06B 63M
Laboratory Of America LH:US USD 18.35B 2.98B
Novartis NOVN:VX USD 181.55B 12.79B
Pfizer PFE:US USD 245.6B 48.58B
Roche Holding ROG:VX CHF 263.11B 68.64B
Tg Therapeutics TGTX:US USD 860M 246M
Verastem VSTM:US USD 160M 56M
YTE INCY:US USD 14.82B 2.01B
Ziopharm Oncology ZIOP:US USD 372M 104M